Biosimilars are highly similar to the reference product notwithstanding minor differences in clinically inactive components. There are no clinically meaningful differences between the […]
Biosimilars – IP Strategy and Commercialization Aspects
Author: LexOrbis
Living The Mirage: Theranos’ Voyage From Bloom To Doom
From being the youngest self-made billionaire to being the CEO of a company hanging on by threads, Elizabeth Holmes had witnessed her rise […]
The IL&FS Crisis: An Analysis of the Order dated May 2, 2019 Passed by the NCLAT
What is IL&FS? The Infrastructure Leasing & Finance Services (IL&FS) Ltd. is a core investment company with most business operations domiciled in separate […]
Importance of expert testimony in patent cases
The grant of a patent invariably follows a thorough examination by expert patent examiners of the patent offices. In some jurisdictions, this grant […]
Protecting IP assets key to success of startups
Recent efforts by the government, investors and innovators have helped facilitate the growth of budding businesses in India. While the initial plans for […]
Delhi High Court injuncts unauthorised audio broadcast of ICC World Cup by various websites and radio channels
Giving tough competition to the climate, the Cricket World Cup Fever is soaring high on the temperature scale. Every brilliant shot is already […]
Product of nature: Patentability issues
Indian position about patent eligibility of the product of nature still remains in the realms of elusive debates for want any judicial precedence […]
Test For Determining Trademark Similarity For Nutraceutical Products Is The Same As The Test Applicable For Pharmaceutical
In a suit for trademark infringement and passing off filed by Sun Pharma Laboratories Ltd. for its mark GLOEYE against Ajanta Pharma Ltd, […]
The Draft Framework For The Regulatory Sandbox For Fintech Start Ups In India
The Reserve Bank of India (“RBI“) released the “Draft Enabling Framework for Regulatory Sandbox” on 18th April 2019 (“Draft Framework“). The Regulatory Sandbox […]
India’s New medical device Regulations
Substances used for in vitro diagnosis, medical device, mechanical contraceptives, disinfectants and insecticides and other notified devices in India are now regulated by […]